Literature DB >> 28876319

Trichomonas vaginalis Prevalence and Correlates in Women and Men Attending STI Clinics in Western Canada.

Jennifer Gratrix1, Sabrina Plitt, LeeAnn Turnbull, Petra Smyczek, Judith Brandley, Ron Scarrott, Prenilla Naidu, Lindsay Bertholet, Max Chernesky, Ron Read, Ameeta E Singh.   

Abstract

Trichomonas vaginalis prevalence (2.8%) in female sexually transmitted infection clinic attendees was within the prevalence of chlamydia (5.8%) and gonorrhea (1.8%), while being very low for male attendees (0.2%). Correlates among women were indigenous ethnicity, other ethnicity, and being symptomatic.

Entities:  

Mesh：

Year:  2017        PMID： 28876319     DOI： 10.1097/OLQ.0000000000000650

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN： 0148-5717            Impact factor:   2.830


  4 in total

1.  Prevalence and genetic diversity of Trichomonas vaginalis clinical isolates in a targeted population in Xinxiang City, Henan Province, China.

Authors:  Zhenchao Zhang; Lixia Kang; Weijuan Wang; Xin Zhao; Yuhua Li; Qing Xie; Shuai Wang; Tong He; Han Li; Tingwei Xiao; Yunchao Chen; Suqiong Zuo; Lingmin Kong; Pengju Li; Xiangrui Li
Journal:  Parasit Vectors       Date:  2018-03-02       Impact factor: 3.876

2.  Clinical Performance of the BD CTGCTV2 Assay for the BD MAX System for Detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis Infections.

Authors:  Barbara Van Der Pol; Edith Torres-Chavolla; Salma Kodsi; Charles K Cooper; Thomas E Davis; Kenneth H Fife; Stephanie N Taylor; Michael H Augenbraun; Charlotte A Gaydos
Journal:  Sex Transm Dis       Date:  2021-02-01       Impact factor: 3.868

3.  Vaginal trichomoniasis.

Authors:  Monica Cenkowski; Beverly Wudel; Vanessa Poliquin
Journal:  CMAJ       Date:  2022-02-14       Impact factor: 8.262

4. 

Authors:  Monica Cenkowski; Beverly Wudel; Vanessa Poliquin
Journal:  CMAJ       Date:  2022-04-04       Impact factor: 8.262
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.